Abstract:<h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Objectives</h3><p>Human immunodeficiency virus (HIV) quasispecies diversity presents a large barrier to the eradication of HIV. The aim of this study was to investigate intrahost HIV quasispecies diversity and evolutionary patterns underpinning the mechanisms of viral pathogenesis during antiretroviral therapy (ART).</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Methods</h3><p>Forty-five participants with HIV-1 infection were enrolled in a follow-up cohort for >84 months in 2004, and received a lamivudine-based first-line ART regimen. Blood samples were collected every 6 months to measure viral load and CD4<sup>+</sup> cell count. Ultra-deep sequencing and phylogenetic analysis were used to characterize the dynamics governing quasispecies diversity of HIV-1 circulating between plasma RNA and cellular DNA of participants with treatment failure (TF, <em>n</em> = 20) or virologic suppression (VS, <em>n</em> = 25).</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Results</h3><p>Analysis of the distribution of intrahost single-nucleotide variations (iSNVs) and their mutated allele frequencies revealed that approximately 65% of the quasispecies co-occurred in plasma HIV RNA and cellular DNA either before or after ART. The number and frequency of iSNVs are more representative of intrahost HIV diversity, and have better generalizability than phylogenetic inference by measurement of phylogenetic associations. Furthermore, drug-resistance-associated mutations (DRAMs) accumulated to high levels, dramatically increasing the DRAM-to-total-mutation ratio for TF patients. Linear regression analysis revealed that emergent mutations accumulated faster in TF patients compared with VS patients, at a rate of 0.02 mutations/day/kb.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Conclusions</h3><p>Based on iSNV analysis, the results demonstrate the dynamics of intrahost HIV quasispecies diversity in patients on ART, and provide a novel insight into the persistence of HIV and development of DRAMs.</p>

Inspecting the interaction between HIV and the immune system through genetic turnover

Recombination Rate and Selection Strength in HIV Intra-patient Evolution

Integrating genealogical and dynamical modelling to infer escape and reversion rates in HIV epitopes

Analysis of a Stochastic Predator-Prey Model with Applications to Intrahost HIV Genetic Diversity

Heritability of the HIV-1 reservoir size and decay under long-term suppressive ART

The effect of interference on the CD8+ T cell escape rates in HIV

Human immunodeficiency virus (HIV) dynamics in secondary lymphoid tissues and the evolution of cytotoxic T lymphocyte (CTL) escape mutants

Phylogenetic Analysis of Population-Based and Deep Sequencing Data to Identify Coevolving Sites in the Nef Gene of HIV-1.

Scaling laws describe memories of host-pathogen riposte in the HIV population

Host-specific Driving Force in Human Immunodeficiency Virus Type 1 Evolution in Vivo.

Dynamics of HIV-1 quasispecies diversity of participants on long-term antiretroviral therapy based on intrahost single-nucleotide variations

Loss and Recovery of Genetic Diversity in Adapting Populations of HIV

Host-pathogen coevolution and the emergence of broadly neutralizing antibodies in chronic infections

Mathematical modeling of escape of HIV from cytotoxic T lymphocyte responses

Simulating within host human immunodeficiency virus 1 genome evolution in the persistent reservoir

Tracking HIV-1 Recombination to Resolve Its Contribution to HIV-1 Evolution in Natural Infection

Deleterious synonymous mutations hitchhike to high frequency in HIV-1 env evolution

Competing HIV Strains and Immune System Response

Using viral diversity to identify HIV-1 variants under HLA-dependent selection in a systematic viral genome-wide screen

A comprehensive stochastic computational model of HIV infection from DNA integration to viral burst

Identification of HIV Rapid Mutations Using Differences in Nucleotide Distribution over Time.